Patents by Inventor Manuel Koch
Manuel Koch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240100621Abstract: An ultrasonic welding device includes a sonotrode with a sonotrode surface, a lateral slide with a lateral slide surface, a touching element with a touching surface and an insertion chamber for inserting joining parts. The insertion chamber is defined in a first axial direction (y) on a first side by the sonotrode surface and in a second axial direction (x) on a second side by the lateral slide surface and on a third side opposing the second side by the touching surface. Furthermore, the ultrasonic welding device includes a first receiving element with a first stop edge and a second receiving element with a second stop edge. The first receiving element and the second receiving element are arranged to be movable in relation to each other between a starting position and an end position.Type: ApplicationFiled: November 5, 2019Publication date: March 28, 2024Applicant: SCHUNK SONOSYSTEMS GMBHInventors: Manuel FEY, Stefan MÜLLER, Rainer WAGENBACH, Waldemar WERNER, Daniel GÜNTHER, Dariusz KOSECKI, Stephan BECKER, Eugen KOCH
-
Publication number: 20230130384Abstract: An interference filter comprises a substrate, a filter stack and at least one absorption layer. The filter stack comprises alternating layers of optical coatings with different refractive indices arranged on the substrate. The at least one absorption layer is comprised of an optically absorbing material which is arranged on the substrate.Type: ApplicationFiled: March 24, 2021Publication date: April 27, 2023Applicant: ams-OSRAM AGInventors: Deborah MORECROFT, Gerhard EILMSTEINER, Manuel KOCH
-
Publication number: 20230119290Abstract: The present invention relates to a column comprising a vascular endothelial growth factor (VEGF) dimer molecule, a method for preparing such a column, a VEGF dimer molecule, an expression vector and a recombinant host cell encoding for a VEGF dimer, as well as uses and methods related thereto.Type: ApplicationFiled: March 18, 2021Publication date: April 20, 2023Applicant: Universität Zu KölnInventors: Henning HAGMANN, Thomas BENZING, Bernhard SCHERMER, Manuel KOCH, Mahsa MATIN
-
Publication number: 20200255983Abstract: A flat clothing for a revolving flat of a carding machine includes a foundation and a plurality of clothing tips formed from U-shaped wire hooks penetrating through the foundation and situated in adjacent rows with a row spacing between successive rows. A row offset in the direction of the length of the foundation is defined between the clothing tips in the adjacent rows such that the clothing tips are not situated one behind the other in successive rows. At least two successive zones are defined, wherein each zone has at least three rows of hooks and the row offset of the first zone differs from the row offset of the second zone. A row spacing between each row in the second zone and a following adjacent row, viewed in the fiber running direction, is different from the row spacing between the row and a preceding adjacent row.Type: ApplicationFiled: February 7, 2020Publication date: August 13, 2020Inventors: Christian Dratva, Manuel Koch, Günter Steinbach
-
Patent number: 9765720Abstract: A method is provided for avoiding incorrect combustion misfire fault detection in an internal combustion engine in a motor vehicle with a dual mass flywheel. In order to detect combustion misfiring, a characteristic variable, which is dependent on the acceleration of the internal combustion engine, is determined continuously during the ongoing operation of the internal combustion engine and compared with a predefined irregular running threshold value. When the irregular running threshold value is exceeded, a combustion misfire is detected, wherein the frequency of detected combustion misfiring, for example at a specific number of crank shaft revolutions, is detected. When a defined frequency threshold is exceeded, a combustion misfire fault detection is activated. When a dual mass flywheel bounce is detected with the simultaneous detection of combustion misfiring, the injection of at least one cylinder is reduced or switched off for a predefined frequency or for a predefined time.Type: GrantFiled: November 12, 2014Date of Patent: September 19, 2017Assignee: Bayerische Motoren Werke AktiengesellschaftInventors: Manuel Koch, Sandra Kustermann
-
Publication number: 20150135810Abstract: A method is provided for avoiding incorrect combustion misfire fault detection in an internal combustion engine in a motor vehicle with a dual mass flywheel. In order to detect combustion misfiring, a characteristic variable, which is dependent on the acceleration of the internal combustion engine, is determined continuously during the ongoing operation of the internal combustion engine and compared with a predefined irregular running threshold value. When the irregular running threshold value is exceeded, a combustion misfire is detected, wherein the frequency of detected combustion misfiring, for example at a specific number of crank shaft revolutions, is detected. When a defined frequency threshold is exceeded, a combustion misfire fault detection is activated. When a dual mass flywheel bounce is detected with the simultaneous detection of combustion misfiring, the injection of at least one cylinder is reduced or switched off for a predefined frequency or for a predefined time.Type: ApplicationFiled: November 12, 2014Publication date: May 21, 2015Inventors: Manuel KOCH, Sandra KUSTERMANN
-
Patent number: 7531625Abstract: ?-netrin nucleic acid molecules and polypeptides are provided. Methods of using the ?-netrin nucleic acid molecules and polypeptides are also provided.Type: GrantFiled: April 26, 2004Date of Patent: May 12, 2009Assignee: The General Hospital CorporationInventors: Pamela Olson, Dale Hunter, William Brunken, Manuel Koch, Robert Burgeson
-
Patent number: 7452684Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic-peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: October 20, 2006Date of Patent: November 18, 2008Assignee: The General Hospital CorporationInventors: Robert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman
-
Patent number: 7390634Abstract: ?-netrin nucleic acid molecules and polypeptides are provided. Methods of using the ?-netrin nucleic acid molecules and polypeptides are also provided.Type: GrantFiled: February 28, 2001Date of Patent: June 24, 2008Assignees: The General Hospital Corporation, Tufts UniversityInventors: Pamela Olson, Dale Hunter, William Brunken, Manuel Koch, Robert Burgeson
-
Publication number: 20070166736Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: October 20, 2006Publication date: July 19, 2007Inventors: Robert Burgeson, Manuel Koch, Douglas Keene, William Brunken, Leena Bruckner-Tuderman
-
Patent number: 7125666Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: July 24, 2002Date of Patent: October 24, 2006Assignee: The General Hospital CorporationInventors: Robert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman
-
Publication number: 20040248178Abstract: &bgr;-netrin nucleic acid molecules and polypeptides are provided. Methods of using the &bgr;-netrin nucleic acid molecules and polypeptides are also provided.Type: ApplicationFiled: April 26, 2004Publication date: December 9, 2004Applicant: The General Hospital Corporation, a Massachusetts corporationInventors: Pamela Olson, Dale Hunter, William Brunken, Manuel Koch, Robert Burgeson
-
Patent number: 6682911Abstract: The present invention is based on the discovery of a novel member of the laminin family, laminin 12. Accordingly, the present invention features a purified or isolated preparation or a recombinant preparation of laminin 12 which includes an &agr;2 subunit, &bgr;1 subunit and a &ggr;3 subunit.Type: GrantFiled: May 1, 2000Date of Patent: January 27, 2004Assignee: The General Hospital CorporationInventors: Robert E. Burgeson, Marie-France Champliaud, Pamela Olson, Manuel Koch, William Brunken
-
Publication number: 20030207347Abstract: &bgr;-netrin nucleic acid molecules and polypeptides are provided. Methods of using the &bgr;-netrin nucleic acid molecules and polypeptides are also provided.Type: ApplicationFiled: February 28, 2001Publication date: November 6, 2003Inventors: Pamela Olson, Dale Hunter, William Brunken, Manuel Koch, Robert Burgeson
-
Publication number: 20030143564Abstract: The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: July 24, 2002Publication date: July 31, 2003Inventors: Robert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman